Faculty of Health, University of Plymouth, Plymouth, UK
South West Liver Unit, University Hospitals Plymouth NHS Trust, Plymouth, UK.
BMJ Open Gastroenterol. 2024 Jan 29;11(1):e001267. doi: 10.1136/bmjgast-2023-001267.
OBJECTIVE: The healthcare burden of alcohol-related liver disease (ARLD) is increasing. ARLD and alcohol use disorder (AUD) is best managed by reduction or cessation of alcohol use, but effective treatments are lacking. We tested whether people with ARLD and AUD admitted to hospital could be recruited to and retained in a trial of Functional Imagery Training (FIT), a psychological therapy that uses mental imagery to reduce alcohol craving. We conducted a multicentre randomised pilot trial of treatment as usual (TAU) versus FIT+TAU in people admitted to hospital with ARLD and AUD. DESIGN: Participants were randomised to TAU (a single session of brief intervention) or FIT+TAU (TAU with one hospital-based FIT session then eight telephone sessions over 6 months). Pilot outcomes included recruitment rate and retention at day 180. Secondary outcomes included fidelity of FIT delivery, alcohol use, and severity of alcohol dependence. RESULTS: Fifty-four participants (mean age 49; 63% male) were recruited and randomised, 28 to TAU and 26 to FIT+TAU. The retention rate at day 180 was 43%. FIT was delivered adequately by most alcohol nurses. 50% of intervention participants completed FIT sessions 1 and 2. There were no differences in alcohol use or severity of alcohol dependence between treatment groups at day 180. CONCLUSION: Participants with ARLD and AUD could be recruited to a trial of FIT versus FIT+TAU. However, retention at day 180 was suboptimal. Before conducting a definitive trial of FIT in this patient group, modifications in the intervention and recruitment/retention strategy must be tested. TRIAL REGISTRATION NUMBER: ISRCTN41353774.
目的:与酒精相关的肝脏疾病(ARLD)的医疗负担正在增加。减少或停止饮酒是治疗 ARLD 和酒精使用障碍(AUD)的最佳方法,但目前缺乏有效的治疗方法。我们测试了患有 ARLD 和 AUD 的人是否可以被招募并留在一项功能性意象训练(FIT)试验中,这是一种使用心理意象来减少酒精渴望的心理治疗。我们在因 ARLD 和 AUD 住院的人群中进行了一项关于常规治疗(TAU)与 FIT+TAU 的多中心随机试验。 设计:参与者被随机分配到 TAU(一次简短干预)或 FIT+TAU(TAU 加一次医院基础 FIT 治疗,然后在 6 个月内进行 8 次电话治疗)。试验的主要结果包括招募率和第 180 天的保留率。次要结果包括 FIT 交付的保真度、饮酒量和酒精依赖严重程度。 结果:共招募并随机分配了 54 名参与者(平均年龄 49 岁;63%为男性),28 名接受 TAU,26 名接受 FIT+TAU。第 180 天的保留率为 43%。大多数酒精护士都能充分提供 FIT。50%的干预参与者完成了前 2 次 FIT 治疗。在第 180 天,两组的饮酒量和酒精依赖严重程度没有差异。 结论:患有 ARLD 和 AUD 的患者可以被招募参加 FIT 与 FIT+TAU 的试验。然而,第 180 天的保留率并不理想。在对该患者群体进行 FIT 的确定性试验之前,必须对干预措施和招募/保留策略进行修改。 试验注册号:ISRCTN41353774。
Health Technol Assess. 2019-9
Hepatol Commun. 2025-4-30
Clin Gastroenterol Hepatol. 2023-8
Aliment Pharmacol Ther. 2020-5-22
Sci Adv. 2019-9-25